Sivec Biotechnologies Patents – Insights & Stats (Updated 2023)

Sivec Biotechnologies has a total of 28 patents globally, out of which 1 has been granted. Of these 28 patents, more than 82% patents are active. United States of America is where Sivec Biotechnologies has filed the maximum number of patents, followed by Canada and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Sivec Biotechnologies.

Sivec Biotechnologies was founded in the year 2016. The Company delivery platform uses non-pathogenic bacteria for targeted intracellular delivery of nucleic acid drugs and vaccines to mucosal epithelial cells.

Do read about some of the most popular patents of Sivec Biotechnologies which have been covered by us in this article and also you can find Sivec Biotechnologies patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Sivec Biotechnologies patent portfolio.

How many patents does Sivec Biotechnologies have?

Sivec Biotechnologies has a total of 28 patents globally. These patents belong to 6 unique patent families. Out of 28 patents, 23 patents are active.

How Many Patents did Sivec Biotechnologies File Every Year?

Sivec Biotechnologies Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantSivec Biotechnologies Applications FiledSivec Biotechnologies Patents Granted
20231
202231
20218
20208
20192
20186

How many Sivec Biotechnologies patents are Alive/Dead?

Sivec Biotechnologies Patent portfolio

How Many Patents did Sivec Biotechnologies File in Different Countries?

Sivec Biotechnologies Worldwide Patent Filing

Countries in which Sivec Biotechnologies Filed Patents

CountryPatents
United States Of America5
Canada4
Japan3
Australia3
China3
Europe3
Korea (South)2

Where are Research Centres of Sivec Biotechnologies Patents Located?

The Research Centre for all the Sivec Biotechnologies patents is the United States of America.

Best Sivec Biotechnologies Patents

US20210222178A1 is the most popular patent in the Sivec Biotechnologies portfolio. It has received 6 citations so far from companies like Curevac Ag, Actym Therapeutics and Shenzhen Ruiji Biotechnology.

What Percentage of Sivec Biotechnologies US Patent Applications were Granted?

Sivec Biotechnologies (Excluding its subsidiaries) has filed 5 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100.0%.

Below are the key stats of Sivec Biotechnologies patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Sivec Biotechnologies?

Law FirmTotal ApplicationsSuccess Rate
Mcgaw Law P C4100.00%
Schlumberger Technology Corporation10%

List of Sivec Biotechnologies Patents

Sivec Biotechnologies PatentsTitle
US11312954B2Transkingdom Platform For Therapeutic Nucleic Acid Delivery
US20220389462A1Transkingdom Platform For Therapeutic Nucleic Acid Delivery
US20220364122A1Bacterial Platform For Delivery Of Gene-Editing Systems To Eukaryotic Cells
US20220229403A1Flow Control Device Openings For Completion Design
US20210222178A1Microbial System For Production And Delivery Of Eukaryote-Translatable Mrna To Eukarya
EP3976073A4A Bacterial Platform For Delivery Of Gene-Editing Systems To Eukaryotic Cells
EP4087934A1A Microbial System For Production And Delivery Of Eukaryote-Translatable Mrna To Eukarya
EP3607070A4A Transkingdom Platform For Therapeutic Nucleic Acid Delivery
CN115335527AMicrobial System For Producing And Delivering Eukaryotic Translatable Mrna To Eukaryotes
CN114630670ABacterial Platform For Delivery Of Gene Editing Systems To Eukaryotic Cells
CN111133107AA Transkingdom Platform For Therapeutic Nucleic Acid Delivery
WO2023211963A2Chimeric Invasin System
CA3220834A1Bacterial Delivery Of Antibodies, Antibody Derivatives, And Polypeptides To Eukaryotic Cells
CA3164395A1A Microbial System For Production And Delivery Of Eukaryote-Translatable Mrna To Eukarya
CA3142425A1A Bacterial Platform For Delivery Of Gene-Editing Systems To Eukaryotic Cells
CA3058474A1A Transkingdom Platform For Therapeutic Nucleic Acid Delivery
JP2022534437A5A Bacterial Platform For The Delivery Of Gene-Editing Systems Into Eukaryotic Cells
JP2023509964AA Microbial System For The Production And Delivery Of Eukaryotic Translatable Mrnas To Eukaryotes
AU2021206307A1A Microbial System For Production And Delivery Of Eukaryote-Translatable Mrna To Eukarya
AU2020286493A1A Bacterial Platform For Delivery Of Gene-Editing Systems To Eukaryotic Cells
AU2018250169A1A Transkingdom Platform For Therapeutic Nucleic Acid Delivery
KR1020220150276AMicrobial Systems For Production And Delivery Of Eukaryotic-Translatable Mrna To Eukaryotes
KR1020220025757ABacterial Platform For Delivering Gene Editing Systems To Eukaryotic Cells
WO2022256519A1Bacterial Delivery Of Antibodies, Antibody Derivatives, And Polypeptides To Eukaryotic Cells
WO2021142458A1A Microbial System For Production And Delivery Of Eukaryote-Translatable Mrna To Eukarya
WO2020247321A1A Bacterial Platform For Delivery Of Gene-Editing Systems To Eukaryotic Cells
WO2018187381A3A Transkingdom Platform For Therapeutic Nucleic Acid Delivery
JP2020512823A5A Cross-Biota Platform For Therapeutic Nucleic Acid Delivery

What are Sivec Biotechnologies key innovation segments?

What Technologies are Covered by Sivec Biotechnologies?

The chart below distributes patents filed by Sivec Biotechnologies in different countries on the basis of the technology protected in patents. It also represents the markets where Sivec Biotechnologies thinks it’s important to protect particular technology inventions.

R&D Focus: How has Sivec Biotechnologies search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Sivec Biotechnologies?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.